All In Biotech

Free tool

FAERS Monitor: Daybue Stix

The FDA Adverse Event Reporting System collects reports from patients, clinicians and manufacturers. Counts are unverified reports, not rates: they rise with how widely a drug is used, how long it has been sold and media attention, a report can name several drugs, and a report does not show the drug caused the event.

Last checked: Nov 20, 2026FDA FAERS (openFDA) last updated: Oct 28, 2026Methods & limitations

Reports naming NDA 219884 or its brand name (Daybue Stix, Trofinetide). Reports on generic versions are filed under their own applications.

Reports

655

Serious

189

29% of reports

Hospitalization

78

Death reported

8

Any cause; not necessarily from the drug

Most reported reactions

MedDRA preferred terms.

  • diarrhoea382
  • underdose125
  • vomiting105
  • seizure78
  • constipation76
  • product use complaint64
  • intentional dose omission54
  • flatulence48
  • weight decreased41
  • abdominal discomfort39
  • weight increased38
  • inappropriate schedule of product administration36
  • condition aggravated34
  • decreased appetite33
  • expulsion of medication29

Reports by year received

View as table
YearReports
20201
20233
20245
202518
2026628

Disproportionality screen

Proportional reporting ratio (PRR): how much more often each reaction appears in this drug's reports than in the other 21,053,504 FAERS reports. Flagged when PRR is at least 2, chi-squared at least 4 and there are 3 or more reports (Evans criteria). A screening statistic only.

ReactionReportsPRR95% CI lowerChi-squared
expulsion of medicationSignal291864.31292.349,301
product use complaintSignal64131.0103.78,099
intentional dose omissionSignal5460.947.23,122
underdoseSignal12555.147.06,595
flatulenceSignal4827.220.71,188
seizureSignal7821.717.61,527
diarrhoeaSignal38219.017.86,703
constipationSignal7611.29.1702
abdominal discomfortSignal397.55.5214
vomitingSignal1057.26.0564
inappropriate schedule of product administrationSignal366.44.7161
weight increasedSignal385.44.0135
weight decreasedSignal414.73.5118
decreased appetiteSignal334.63.389
condition aggravatedSignal343.62.662

A high PRR for a reaction that is also the condition being treated (for example "disease progression" for a cancer drug) is expected and is not a safety signal.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.